Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Kenvue Inc. Common Stock
(NY:
KVUE
)
14.37
+0.13 (+0.91%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kenvue Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
These 3 Dividend Stocks Yield More Than 5% and Have Payout Ratios Over 100%. Are Dividend Cuts Coming?
Today 7:05 EDT
A high payout ratio can be concerning, but that doesn't always mean the dividend in question is destined to be cut.
Via
The Motley Fool
Topics
Government
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
October 30, 2025
Via
MarketBeat
What's going on in today's session: S&P500 most active stocks
October 29, 2025
Looking for the most active stocks in the S&P500 index on Wednesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via
Chartmill
Nvidia To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Wednesday
October 29, 2025
Via
Benzinga
Looking Into Kenvue Inc's Recent Short Interest
October 21, 2025
Via
Benzinga
Kenvue Stock Climbs Premarket, Day After Record Slide On UK Lawsuit: Retail Bulls Remain Unshaken
October 17, 2025
Via
Stocktwits
This Stride Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
October 29, 2025
Via
Benzinga
Kenvue Declares Quarterly Cash Dividend
October 29, 2025
From
Kenvue
Via
Business Wire
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
October 28, 2025
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women.
Via
Benzinga
Topics
Lawsuit
Kenvue Stock Drops After Texas Attorney General Sues Company Alleging Deceptive Marketing Of Tylenol
October 28, 2025
The lawsuit comes on the heels of President Trump linking Tylenol to autism.
Via
Stocktwits
Topics
Government
Lawsuit
Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy?
October 27, 2025
Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy?
Via
The Motley Fool
Topics
Initial Public Offering
Renaissance Capital Bets Big on Tylenol and Kenvue (KVUE) By Purchasing Over 351,000 Shares
October 27, 2025
Renaissance Capital Bets Big on Tylenol and Kenvue (KVUE) By Purchasing Over 351,000 Shares
Via
The Motley Fool
Kenvue to Announce Third Quarter 2025 Results on November 6, 2025
October 27, 2025
From
Kenvue
Via
Business Wire
3 Healthcare Stocks Paying the Highest Dividends of 2025
October 27, 2025
If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.
Via
The Motley Fool
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.
October 26, 2025
Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).
Via
The Motley Fool
Topics
Government
Renaissance Capital Sells Off 176K CRBG Shares Worth $6.3 Million
October 21, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Retirement
These S&P500 stocks are gapping in today's session
October 20, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Monday. Discover the gap up and gap down stocks in the S&P500 index.
Via
Chartmill
3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October
October 20, 2025
These three stocks have elevated yields and attractive dividend histories.
Via
The Motley Fool
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
October 19, 2025
Kenvue could start to recover in 2026.
Via
The Motley Fool
Johnson & Johnson's M&A Strategy Is the Real Story for Investors
October 18, 2025
Johnson & Johnson’s rumored Protagonist buyout demonstrates its proven M&A strategy: divesting low-growth units to fund high-margin, innovative assets.
Via
MarketBeat
Uncover the latest developments among S&P500 stocks in today's session.
October 17, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via
Chartmill
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session.
October 17, 2025
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via
Chartmill
Which S&P500 stocks are moving on Friday?
October 17, 2025
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Via
Chartmill
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday
October 17, 2025
Via
Benzinga
Why Kenvue Stock Tumbled by 13% on Thursday
October 16, 2025
The company's baby powder product is under legal fire once again.
Via
The Motley Fool
Topics
Lawsuit
Kenvue's Dual Dilemma: Tylenol and Talc Fears Trigger Sector Jitters
October 16, 2025
New York, NY – October 16, 2025 – The Consumer Staples and Healthcare sectors of the S&P 500 are experiencing a notable day of underperformance, largely overshadowed by the precipitous stock plunge of...
Via
MarketMinute
Topics
Death
Government
Lawsuit
Johnson & Johnson Plunges Amidst Escalating Talc Litigation: Billions at Stake as Legal Battles Intensify
October 16, 2025
New York, NY – October 16, 2025 – Johnson & Johnson (NYSE: JNJ), once considered a stalwart of stability, is currently navigating turbulent waters, finding itself among the market's bottom performers...
Via
MarketMinute
Topics
Bankruptcy
Death
Lawsuit
Kenvue (KVUE) Plunges Amidst Dual Headwinds: Tylenol Fears and Escalating Talc Litigation
October 16, 2025
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As...
Via
MarketMinute
Topics
Government
Lawsuit
Discover which S&P500 stocks are making waves on Thursday.
October 16, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.
Via
Chartmill
These S&P500 stocks are the most active in today's session
October 16, 2025
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.